Sign Out
Hypersensitivity to empagliflozin or linagliptin or any of the excipients.
Patients with eGFR less than 45 ml/min/1.73 m2, severe renal impairment, end-stage renal disease and patients on dialysis.
UserName
Profession Email
Profession Email
